Third Wave Tech to be bought out by Hologic for $580M
Third Wave Technologies, Inc. (Nasdaq:TWTI), which develops molecular diagnostic reagents for a variety of DNA and RNA analysis, said early this morning that it will be acquired by diagnostics and medical imaging systems supplier Hologic, Inc. (Nasdaq:HOLX) for $580 million, or $11.25 per share. The purchase price represents a 24% premium over Third Wave's average trading price over the last three months.
Shares gained 6%, or $0.63, to $11.13 ahead of the opening bell. For detailed price information and recent news stories about Third Wave Technologies, click TWTI.
